Gland Pharma Closes Trading Window from Dec 27 for Q3 FY26 Results
Gland Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Saturday, December 27, 2025. The trading window will r...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Gland Pharma Limited in the news today?
Gland Pharma Limited (GLAND) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window, which is a standard procedure before financial results are announced. it does not contain any information that positively or negatively impacts the company's outlook.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Gland Pharma Closes Trading Window from Dec 27 for Q3 FY26 Results
December 26, 2025, 07:15 AM
Top Queries to Ask About Gland Pharma Limited
Gland Pharma Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Saturday, December 27, 2025. The trading window will remain shut until 48 hours after the declaration of the Unaudited Financial Results for the quarter and nine months ending on December 31, 2025.
The company will intimate the date of the Board Meeting to consider and approve these financial results in due course.
This announcement is made in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
